Clinical Trial Search

Primary: Elicited Imitation Memory Task - Short Delay Memory Measure: 6 Months — 0.252; 0.183 change in percentage correct

Primary: Change in the Alcohol Use Disorders Identification Test (AUDIT) Score Over Time — -5.8; -4.0 score on a scale

Primary: Number of Participants With Negative Urinalysis for Alcohol Metabolite (EtG) — 44 Participants

Primary: BrainHQ Learning Rate — 867.6; 861.7 milliseconds

Primary: Parent Awareness of Own Emotion Score for Sadness at Baseline and Immediate Post-intervention (8 Weeks) — 32.73; 32.37; 32.20; 32.47 score on a scale — p=.523

Primary: Pittsburg Side-Effects Scale: Motor Tics — 0.15; 0.20; 0.31; 0.27 units on a scale

Primary: Attachment Classification — 0; 0; 0; 0 participants

Primary: Change in Mean Knowledge About FASD From Baseline to 6 Weeks — 15.50; 17.14; 16.57; 17.14 units on a scale — p=0.587

Primary: Eyberg Child Behavior Inventory at Baseline and 3-Month Follow-Up — 69.31; 65.62 score on a scale

Primary: Alcohol Use — 86; 82; 131; 137 Participants

Primary: Urine Ethylglucuronide (EtG) Testing — 0 Participants

Primary: Mean Change in Subjective Well-being From Baseline to 6-week Follow-up on the Personal Well-Being Index - Intellectual Disability Version — 3.51; 3.59 units on a scale…

Primary: Eyberg Child Behavior Inventory - Intensity at Baseline and 12-week Follow-Up — 68.33; 69.13; 68.40; 64.47 T-score — p=.602

Primary: Clinical Global Impression- Severity Scale (CGI-S) — 7.0 units on a scale

Primary: Side Effects of Choline Bitartrate — 8; 10; 8; 9 participants

Primary: Fetal Heart Rate — 142.34 beats per minute

Primary: Level of Intoxication (Subjective Response) on Each Condition Day After Drinking Relative to How They Felt When Arriving to the Lab on That Respective Day )Prior to…

Primary: Number of Participants Reporting Risky Alcohol Use — 99; 86; 60; 48 Participants

Primary: Form-90 Timeline Followback Interview — .78; .64 proportion of days abstinent

Primary: Change in Blood Oxygenation Level Dependent (BOLD) Activation in the Amygdala During "Win" Monetary Incentive Delay (MID) Task Between Placebo and Study Medication…

Primary: Brain Response — .015; .010; -.013; .08 unitless — p=<0.05

Primary: Percentage of Screen Eligible Who Enroll — 28; 5 Participants

Primary: Change in Mean Value of Parental Pro-sipping Beliefs Score — 0.13; 0.08 score on a scale

Primary: Change in Bile Salt Metabolism (C4 )Levels to Determine Effect of FXR

Primary: Alcohol Abstinence — 2.9; 2.6 Samples — p=0.66

Primary: Bioavailability — 1.95; 1.80; 3.00; 0.80 mol%

Primary: Intervention Effects on Brain Functional Connectivity — 0.05; 0.19 percentage of Blood Oxygenation Level De

Primary: Time to First Post-visit Drinking Day — 97; 44; 366; 366 days

Primary: TOPSE: Group Mean Change at 6 Weeks and 4 Months on the Tool of Parenting Self-Efficacy — 8.77; 7.50; 8.70; 7.65 score on a scale — p=0.014

Primary: Number of Participants With Adverse Events (AEs), Serious AEs, and AEs Leading to Study Discontinuation — 13; 6; 8; 21 Participants